Cargando…

Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis

Mannan (polysaccharide) conjugated with a myelin oligodendrocyte glycoprotein (MOG) peptide, namely (KG)(5)MOG(35–55), represents a potent and promising new approach for the immunotherapy of Multiple Sclerosis (MS). The MOG(35–55) epitope conjugated with the oxidized form of mannan (poly-mannose) vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Androutsou, Maria-Eleni, Nteli, Agathi, Gkika, Areti, Avloniti, Maria, Dagkonaki, Anastasia, Probert, Lesley, Tselios, Theodore, Golič Grdadolnik, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593956/ https://www.ncbi.nlm.nih.gov/pubmed/33066323 http://dx.doi.org/10.3390/ijms21207566

Ejemplares similares

Maturation of circulating Ly6C(hi)CCR2(+) monocytes by mannan-MOG induces antigen-specific tolerance and reverses autoimmune encephalomyelitis
por: Dagkonaki, Anastasia, et al.
Publicado: (2022)

A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87–99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis
por: Emmanouil, Mary, et al.
Publicado: (2018)

Mannan-MOG35-55 Reverses Experimental Autoimmune Encephalomyelitis, Inducing a Peripheral Type 2 Myeloid Response, Reducing CNS Inflammation, and Preserving Axons in Spinal Cord Lesions
por: Dagkonaki, Anastasia, et al.
Publicado: (2020)

Implications of Metal Binding and Asparagine Deamidation for Amyloid Formation
por: Sadakane, Yutaka, et al.
Publicado: (2018)

Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal Antibodies
por: Yan, Qingrong, et al.
Publicado: (2018)

Deamidation Reactions of Asparagine- and Glutamine-Containing Dipeptides Investigated by Ion Spectroscopy
por: Kempkes, Lisanne J. M., et al.
Publicado: (2016)

Protein asparagine deamidation prediction based on structures with machine learning methods
por: Jia, Lei, et al.
Publicado: (2017)

Machine Learning Enables Accurate Prediction of Asparagine Deamidation Probability and Rate
por: Delmar, Jared A., et al.
Publicado: (2020)

Machine Learning Enables Accurate Prediction of Asparagine Deamidation Probability and Rate
por: Delmar, Jared A., et al.
Publicado: (2019)

Characterization of N-Terminal Asparagine Deamidation and Clipping of a Monoclonal Antibody
por: Zhen, Jing, et al.
Publicado: (2023)

Conformational Control of Fast Asparagine Deamidation in a Norovirus Capsid Protein
por: Creutznacher, Robert, et al.
Publicado: (2023)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)

Mechanisms of Deamidation of Asparagine Residues and Effects of Main-Chain Conformation on Activation Energy
por: Kato, Koichi, et al.
Publicado: (2020)

Structure and chromosomal localization of the gene for the oligodendrocyte-myelin glycoprotein
Publicado: (1990)

Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
por: Nakajima, Hideki, et al.
Publicado: (2015)

Limbic Encephalitis with Anti-myelin Oligodendrocyte Glycoprotein Antibody
por: Takasone, Ken, et al.
Publicado: (2020)

The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes
Publicado: (1989)

Glycolic Acid-Catalyzed Deamidation of Asparagine Residues in Degrading PLGA Matrices: A Computational Study
por: Manabe, Noriyoshi, et al.
Publicado: (2015)

Atypical Asparagine Deamidation of NW Motif Significantly Attenuates the Biological Activities of an Antibody Drug Conjugate
por: Cao, Mingyan, et al.
Publicado: (2023)

Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
por: Ramanathan, Sudarshini, et al.
Publicado: (2014)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
por: Tea, Fiona, et al.
Publicado: (2019)

Gray Matter Encephalomyelitis with Anti-Myelin Oligodendrocyte Glycoprotein Antibody
por: Morizumi, Teruya, et al.
Publicado: (2020)

Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease
por: Kim, Hyunjin, et al.
Publicado: (2020)

T-cell responses to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis
por: Ewing, C., et al.
Publicado: (1998)

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
por: Sechi, Elia, et al.
Publicado: (2021)

Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease with Frequent Cerebellitis
por: Ishikura, Teruyuki, et al.
Publicado: (2022)

The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway
por: Lerch, Magdalena, et al.
Publicado: (2023)

Anaesthetic concerns in pregnancy associated with myelin oligodendrocyte glycoprotein encephalomyelitis
por: Kuberan, Aswini, et al.
Publicado: (2022)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
por: Perez-Giraldo, Gina, et al.
Publicado: (2023)

Early blood neurofilament light chain and myelin oligodendrocyte glycoprotein antibody levels associate with different disease courses of myelin oligodendrocyte glycoprotein-associated disease in children
por: Horellou, Philippe, et al.
Publicado: (2023)

Rational Design and Synthesis of Altered Peptide Ligands based on Human Myelin Oligodendrocyte Glycoprotein 35–55 Epitope: Inhibition of Chronic Experimental Autoimmune Encephalomyelitis in Mice
por: Tselios, Theodore, et al.
Publicado: (2014)

Deamidation of Protonated Asparagine–Valine Investigated by a Combined Spectroscopic, Guided Ion Beam, and Theoretical Study
por: Kempkes, L. J. M., et al.
Publicado: (2018)

Myelin oligodendrocyte glycoprotein antibody-associated disease: characterising clinical disease
por: Willis, M. D., et al.
Publicado: (2018)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
por: Peschl, Patrick, et al.
Publicado: (2017)

Oligodendrocyte myelin glycoprotein as a novel target for pathogenic autoimmunity in the CNS
por: Gerhards, Ramona, et al.
Publicado: (2020)

Myelin Oligodendrocyte Glycoprotein Antibody Syndrome and Seizures: A Diagnostic Clue
por: Agarwal, Ayush, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series
por: Nurul-Ain, Masnon, et al.
Publicado: (2021)

Clinical and Radiological Features of Myelin Oligodendrocyte Glycoprotein-Associated Myelitis in Adults
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
por: Kohyama, Kuniko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9qd7t54b5ss7qog4f4304lbcg6